Can a prostate cancer genomic profile predict if the tumor will recur?
Our research is moving to where genomic profiles can be used to identify prostate cancers that are more likely to recur following surgery. We are collecting more information about this in our clinical trial CALGB 90203. This trial is open to men with high-risk, localized prostate cancer having removal of the prostate gland (radical prostatectomy). Click here for information on our available clinical trials or call 919-681-2056 to speak to Dr. Phillip Febbo’s research team.